Volume 8 Issue 3, Mar 2023

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 8 Issue 3, Mar 2023:
Letter
Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
Xiaocong Pang,Xiaojiao Sun,Yanlun Gu,Xu He,Kan Gong  ORCID: orcid.org/0000-0001-7195-677X,Song Song,Jixin Zhang,Jie Xia,Zhenming Liu &…Yimin Cui